{
    "startDate": "2020-04-01",
    "endDate": "2020-06-30",
    "year": "2020",
    "quarter": "Q2",
    "symbol": "HTBX",
    "data": {
        "bs": [
            {
                "label": "Restricted cash from cash flows",
                "concept": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
                "unit": "usd",
                "value": 20668241
            },
            {
                "label": "Restricted cash from cash flows",
                "concept": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
                "unit": "usd",
                "value": 20668241
            }
        ],
        "cf": [],
        "ic": [
            {
                "label": "Revenue From Contract With Customer Including Assessed Tax",
                "concept": "RevenueFromContractWithCustomerIncludingAssessedTax",
                "unit": "usd",
                "value": 593165
            },
            {
                "label": "Research and development",
                "concept": "ResearchAndDevelopmentExpense",
                "unit": "usd",
                "value": 2790797
            },
            {
                "label": "General and administrative",
                "concept": "GeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 1801674
            },
            {
                "label": "Change in fair value of contingent consideration.",
                "concept": "htbx:ChangeInFairValueOfContingentConsideration",
                "unit": "usd",
                "value": 843000
            },
            {
                "label": "Operating Expenses",
                "concept": "OperatingExpenses",
                "unit": "usd",
                "value": 5435471
            },
            {
                "label": "Operating Income (Loss)",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": -4842306
            },
            {
                "label": "Fair Value Adjustment of Warrants",
                "concept": "FairValueAdjustmentOfWarrants",
                "unit": "usd",
                "value": 24363
            },
            {
                "label": "Interest income",
                "concept": "InterestIncomeOther",
                "unit": "usd",
                "value": 56080
            },
            {
                "label": "Other income, net",
                "concept": "OtherNonoperatingIncomeExpense",
                "unit": "usd",
                "value": 273771
            },
            {
                "label": "Nonoperating Income (Expense)",
                "concept": "NonoperatingIncomeExpense",
                "unit": "usd",
                "value": 305488
            },
            {
                "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
                "concept": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
                "unit": "usd",
                "value": -4536818
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -4536818
            },
            {
                "label": "Net loss - non-controlling interest",
                "concept": "NetIncomeLossAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -82388
            },
            {
                "label": "Net loss (income)",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -4454430
            },
            {
                "label": "Net loss per share attributable to Heat Biologics, Inc.-basic and diluted",
                "concept": "EarningsPerShareBasicAndDiluted",
                "unit": "usd/shares",
                "value": -0.05
            },
            {
                "label": "Weighted-average number of common shares used in net loss per share attributable to Heat Biologics, Inc.-basic and diluted",
                "concept": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
                "unit": "shares",
                "value": 87930846
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -4536818
            },
            {
                "label": "Unrealized gain (loss) on foreign currency translation",
                "concept": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
                "unit": "usd",
                "value": -179510
            },
            {
                "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
                "concept": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -4716328
            },
            {
                "label": "Comprehensive loss - non-controlling interest",
                "concept": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -82388
            },
            {
                "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
                "concept": "ComprehensiveIncomeNetOfTax",
                "unit": "usd",
                "value": -4633940
            }
        ]
    }
}